How to Stabilize Drug Prices and Reduce Shortages
Civica Rx is a new kind of generic drug company that aims to directly address critical drug shortages experienced by healthcare systems and challenge the pricing practices of incumbent drug makers. The venture, which was announced in January 2018 was started by Intermountain Healthcare, SSM Health, Trinity Health, Mayo Clinic, HCA, Catholic Health Initiatives (now Common Spirit) and Providence St. Joseph’s health systems. Civica has signed up over 800 hospitals to date with the intention of assuring stability in supply and pricing for generic medications in shortage.
During this web conference, Heather Wall, Civica Rx’s Chief Commercial Officer will provide an update on Civica’s plans.
Things You’ll Learn:
- How CivicaRx plans to ensure a stable and predictable supply of essential generic drugs
- How CivicaRx's model corrects failures in today's generic drug market
- How provider organizations can partner with CivicaRx to increase access to generic drugs